Prime Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Prime Pharmaceuticals Private Limited

Prime Pharmaceuticals Private Limited, a active private limited company, was established on 11 September 1995 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24231MH1995PTC092543. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹6.18 M.

Formerly known as Prime Pharmaceuticals Limited. It upholds a compliant status. Employing 46 professional, Its leadership includes Devang Subodh Thakar (Director), Manish Patel (Director), Manish Navnitrai Vora (Director). Past directors included Anil Kumar Vora, Manish Navnitrai Vora, Ramamurthy Ayyavuthevar. It holds ₹85.00 Cr open charges and ₹17.35 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 601, 6Th Floor, Kamla Executive Park,, A K Road, Andheri East,, Mumbai, Maharashtra, 400059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MH1995PTC092543

  • Registration Number

    092543

  • Incorporation Date

    11 September 1995

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹6.18 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 6.18 M
  • Company Age 30 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 85.00 Cr
  • Satisfied Charges ₹ 17.35 Cr
  • Revenue Growth **** 28.12%
  • Profit Growth **** -76.79%
  • Ebitda **** -49.19%
  • Net Worth 13.46%
  • Total Assets **** 109.65%
Company report

Prime Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Prime Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Prime Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Devang Subodh Thakar Director 02 Apr 1998 Current
Manish Patel Director 02 Apr 1998 Current
Manish Navnitrai Vora Director 23 May 2024 Current
Ramamurthy Ayyavuthevar Director 05 Feb 2021 Current
Ashish Anil Vora Director 11 Sep 1995 Current
Irfan Vazirally Director 20 May 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Jul 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 01 Sep 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prime Pharmaceuticals.

Prime Pharmaceuticals Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 28.12% increase. The company also saw a substantial fall in profitability, with a 76.79% decrease in profit. The company's net worth Soared by an impressive increase of 13.46%.

Prime Pharmaceuticals revenue growth over time
Prime Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 28.12%
*******
*******
*******
*******
Revenue from Operations
*******
 31.62%
*******
*******
*******
*******
Total Assets
*******
 109.65%
*******
*******
*******
*******
Profit or Loss
*******
 -76.79%
*******
*******
*******
*******
Net Worth
*******
 13.46%
*******
*******
*******
*******
EBITDA
*******
 -49.19%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prime Pharmaceuticals?

In 2024, Prime Pharmaceuticals had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹850,000,000.00

Satisfied Charges

₹173,475,000.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 65.00 Cr
  • Others : 20.00 Cr
Latest Charge Details
Date Lender Amount Status
28 Nov 2024 Others ₹20.00 Cr Open
18 May 2023 Citi Bank N.A. ₹65.00 Cr Open
17 Jul 2021 Others ₹5.00 M Satisfied
25 May 2021 Others ₹7.50 M Satisfied
06 May 2017 Others ₹10.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Prime Pharmaceuticals?

Prime Pharmaceuticals has a workforce of 46 employees as of Jan 09, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prime Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prime Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 20.00 Cr registered on 28 Nov 2024 with Charge ID 101014284 was modified on 30 Sep 2025. was completed.

  • Annual General Meeting

    Prime Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Prime Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    The activity A charge with Citi Bank N.A. of Rs. 65.00 Cr registered on 18 May 2023 with Charge ID 100722743 was modified on 22 Jan 2025. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101014284 was registered on 28 Nov 2024. was completed.

  • Director Appointment

    Manish Navnitrai Vora was appointed as a Director was appointed as a Director on 23 May 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Prime Pharmaceuticals Private Limited?

The CIN of Prime Pharmaceuticals Private Limited is U24231MH1995PTC092543.

Where is Prime Pharmaceuticals Private Limited headquartered?

Prime Pharmaceuticals Private Limited is headquartered at 601, 6Th Floor, Kamla Executive Park,, A K Road, Andheri East,, Mumbai, Maharashtra, 400059.

When was Prime Pharmaceuticals Private Limited incorporated?

Prime Pharmaceuticals Private Limited was incorporated on 11 September 1995.

Who are the current directors of Prime Pharmaceuticals Private Limited?

The current directors of Prime Pharmaceuticals Private Limited are

What is the primary industry of Prime Pharmaceuticals Private Limited?

The primary industry of Prime Pharmaceuticals Private Limited is Manufacturing.

Is Prime Pharmaceuticals Private Limited a listed company?

Prime Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Prime Pharmaceuticals Private Limited?

The authorized capital of Prime Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹6.18 M.

What is the compliance status of Prime Pharmaceuticals Private Limited?

The compliance status of Prime Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available